Screener
Vera Therapeutics VERA Interest Income
Interest Income at other companies
Other financials
Where this comes from
Reported directly by Vera Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:InvestmentIncomeInterest.
The source filing: Vera Therapeutics’s 10-Q, filed May 7, 2026.
- Filed
- May 7, 2026, 4:33 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-212143
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Total operating expenses | 125,132 | 57,194 |
| Loss from operations | (125,132) | (57,194) |
| Other income (expense): | ||
| Interest income | 6,355 | 6,906 |
| Interest expense | (1,823) | (1,792) |
| Other (expense) income, net | (432) | 386 |
| Total other income, net | 4,100 | 5,500 |
| Net loss | $(121,032) | $(51,694) |
Item 1. Financial Statements
FAQ
- What is Vera Therapeutics's interest income?
- Vera Therapeutics (VERA) reported interest income of $6.36M in Q1 2026.
- How has Vera Therapeutics's interest income changed year-over-year?
- Vera Therapeutics's interest income decreased by 8.0% year-over-year, from $6.91M to $6.36M.
- What is the long-term trend for Vera Therapeutics's interest income?
- Over 4 years (2021 to 2025), Vera Therapeutics's interest income has grown at a 535.6% compound annual growth rate (CAGR), from $15K to $24.48M.
- What does interest income mean?
- Income earned from interest-bearing assets including cash deposits, money market funds, treasury securities, corporate bonds, and customer financing receivables.
Ask your AI about Vera Therapeutics's interest income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude